A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease
Clinical trial NCT02662582 · COMPLETED
Trial details
- NCT number
- NCT02662582
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-30
- Primary completion
- 2018-06-08
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.